Amica Retiree Medical Trust held its position in shares of Accenture Plc (NYSE:ACN) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,927 shares of the information technology services provider’s stock at the end of the first quarter. Amica Retiree Medical Trust’s holdings in Accenture Plc were worth $471,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp raised its position in shares of Accenture Plc by 3.8% in the fourth quarter. State Street Corp now owns 24,690,781 shares of the information technology services provider’s stock valued at $2,892,040,000 after buying an additional 904,933 shares during the period. FMR LLC increased its stake in shares of Accenture Plc by 11.2% in the fourth quarter. FMR LLC now owns 11,258,236 shares of the information technology services provider’s stock valued at $1,318,678,000 after buying an additional 1,129,888 shares in the last quarter. Northern Trust Corp increased its stake in shares of Accenture Plc by 0.7% in the third quarter. Northern Trust Corp now owns 10,155,135 shares of the information technology services provider’s stock valued at $1,240,653,000 after buying an additional 72,055 shares in the last quarter. Fiduciary Management Inc. WI increased its stake in shares of Accenture Plc by 1.0% in the fourth quarter. Fiduciary Management Inc. WI now owns 6,805,012 shares of the information technology services provider’s stock valued at $797,071,000 after buying an additional 67,897 shares in the last quarter. Finally, Longview Partners Guernsey LTD increased its stake in shares of Accenture Plc by 0.8% in the third quarter. Longview Partners Guernsey LTD now owns 6,214,163 shares of the information technology services provider’s stock valued at $759,184,000 after buying an additional 48,029 shares in the last quarter. 77.38% of the stock is currently owned by institutional investors and hedge funds.
Accenture Plc (NYSE:ACN) opened at 123.10 on Friday. The company has a market cap of $76.33 billion, a PE ratio of 20.51 and a beta of 1.17. The stock’s 50 day moving average is $119.76 and its 200 day moving average is $119.56. Accenture Plc has a 12 month low of $108.66 and a 12 month high of $126.53.
Accenture Plc (NYSE:ACN) last posted its quarterly earnings data on Thursday, March 23rd. The information technology services provider reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.03. Accenture Plc had a net margin of 12.34% and a return on equity of 46.99%. The company had revenue of $8.32 billion for the quarter, compared to the consensus estimate of $8.34 billion. During the same quarter in the previous year, the firm posted $1.34 EPS. The business’s revenue was up 4.7% compared to the same quarter last year. Equities analysts predict that Accenture Plc will post $5.86 earnings per share for the current year.
The business also recently disclosed a semiannual dividend, which was paid on Monday, May 15th. Stockholders of record on Thursday, April 13th were issued a dividend of $1.21 per share. This is an increase from Accenture Plc’s previous semiannual dividend of $1.02. The ex-dividend date of this dividend was Tuesday, April 11th. This represents a dividend yield of 2.03%. Accenture Plc’s payout ratio is presently 35.85%.
ILLEGAL ACTIVITY NOTICE: This report was originally published by BBNS and is the sole property of of BBNS. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://baseballnewssource.com/markets/amica-retiree-medical-trust-has-471000-stake-in-accenture-plc-acn/848869.html.
ACN has been the subject of several recent research reports. Evercore ISI reiterated an “outperform” rating on shares of Accenture Plc in a report on Saturday, March 25th. Zacks Investment Research downgraded Accenture Plc from a “hold” rating to a “sell” rating in a report on Wednesday, March 1st. Wedbush reiterated an “outperform” rating and issued a $135.00 price target on shares of Accenture Plc in a report on Wednesday, March 29th. Deutsche Bank AG increased their price target on Accenture Plc from $127.00 to $133.00 and gave the company a “buy” rating in a report on Friday, March 24th. Finally, Stifel Nicolaus increased their price target on Accenture Plc from $128.00 to $138.00 and gave the company a “buy” rating in a report on Tuesday, March 21st. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Accenture Plc currently has a consensus rating of “Buy” and an average price target of $128.16.
In other news, General Counsel Chad T. Jerdee sold 7,300 shares of the business’s stock in a transaction dated Monday, March 27th. The shares were sold at an average price of $119.27, for a total transaction of $870,671.00. Following the transaction, the general counsel now owns 22,912 shares in the company, valued at approximately $2,732,714.24. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Richard P. Clark sold 10,715 shares of the business’s stock in a transaction dated Monday, March 27th. The stock was sold at an average price of $119.31, for a total transaction of $1,278,406.65. Following the transaction, the insider now owns 18,987 shares in the company, valued at approximately $2,265,338.97. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 82,626 shares of company stock worth $9,919,492. Insiders own 0.21% of the company’s stock.
Accenture Plc Company Profile
Accenture plc is a professional services company serving clients in various industries and in geographic regions, including North America, Europe and Growth Markets. The Company provides management and technology consulting services. Its segments include Communications, Media and Technology; Financial Services; Health and Public Service; Products, and Resources.
Receive News & Ratings for Accenture Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture Plc and related companies with our FREE daily email newsletter.